Solicitation of Nominations for Membership on the Advisory Committee on Blood Safety and Availability, 41508-41509 [E7-14611]
Download as PDF
<![CDATA[
41508
Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices
holding companies may be obtained
from the National Information Center
Web site at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than August 24,
2007.
A. Federal Reserve Bank of Chicago
(Burl Thornton, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
1. Greenwoods Financial Group, Inc.,
Rio, Wisconsin; to become a bank
holding company by acquiring 100
percent of the voting shares of
Greenwood’s Bancorporation, Inc., and
thereby indirectly acquire The
Greenwood’s State Bank, both of Lake
Mills, Wisconsin.
In connection with this application,
Applicant also has applied to acquire
The Greenwood’s Financial Services,
Inc., Lake Mills, Wisconsin, and thereby
engage in the sale of insurance in a town
less than 5,000, pursuant to section
225.28(b)(11)(iii)(A) of Regulation Y.
Board of Governors of the Federal Reserve
System, July 25, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E7–14655 Filed 7–27–07; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the Advisory
Committee on Blood Safety and
Availability
Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: The Office of Public Health
and Science (OPHS) is seeking
nominations of qualified individuals to
be considered for appointment as
members of the Advisory Committee on
Blood Safety and Availability (ACBSA).
ACBSA is a Federal advisory committee
in the Department of Health and Human
Services. Management support for the
activities of this Committee are the
responsibility of the OPHS.
The qualified individuals will be
nominated to the Secretary of the
Department of Health and Human
Services for consideration of
appointment as members of the ACBSA.
Members of the Committee, including
the Chair, are appointed by the
Secretary. Members are invited to serve
VerDate Aug<31>2005
22:24 Jul 27, 2007
Jkt 211001
on the Committee for overlapping fouryear terms.
DATES: All nominations must be
received no later than 4 p.m. EDT on
August 31, 2007 at the address listed
below.
ADDRESSES: All nominations should be
mailed or delivered to Dr. Jerry
Holmberg, Executive Secretary,
Advisory Committee on Blood Safety
and Availability; Office of Public Health
and Science; Department of Health and
Human Services; 1101 Wootton
Parkway, Suite 250; Rockville, MD
20852. Telephone: (240) 453–8803.
FOR FURTHER INFORMATION CONTACT: Dr.
Jerry Holmberg, Executive Secretary,
Advisory Committee on Blood Safety
and Availability. See ADDRESSES for
contact information.
SUPPLEMENTARY INFORMATION: The
Advisory Committee on Blood Safety
and Availability shall provide advice to
the Secretary and to the Assistant
Secretary for Health. The Committee
shall advise on a range of policy issues
to include: (1) Definition of public
health parameters around safety and
availability of the blood and blood
products, (2) broad public health,
ethical and legal issues related to
transfusion and transplantation safety,
and (3) the implications for safety and
availability of various economic factors
affecting product cost and supply.
The ACBSA consists of 18 voting
members. The Committee is composed
of 12 public members, including the
Chair, and six (6) representative
members. The public members are
selected from State and local
organizations, advocacy groups,
provider organizations, academic
researchers, ethicists, private
physicians, scientists, consumer
advocates, legal organizations, and from
among communities of persons who are
frequent recipients of blood or blood
products. The six individuals who are
appointed as official representative
members are selected to serve the
interests of the blood and blood
products industry or professional
organizations associated with
transfusion or transplantation safety.
The representative members are selected
from the following groups: The AABB,
the Plasma Protein Therapeutic
Association (PPTA), one of the two
major distributors of blood on a rotating
basis, a trade organization or
manufacturer of blood, plasma, or other
tissue test kits or equipment, and a
purchaser of blood and blood products
from major hospital organization.
All ACBSA members are authorized
to receive the prescribed per diem
allowance and reimbursement for travel
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
expenses that are incurred to attend
meetings and conduct Committeerelated business, in accordance with
Standard Government Travel
Regulations. Individuals who are
appointed to serve as public members
are authorized also to receive a stipend
for attending Committee meetings and
to carry out other Committee-related
business. Individuals who are appointed
to serve as representative members for a
particular interest group or industry are
not authorized to receive a stipend for
the performance of these duties.
This announcement is to solicit
nominations of qualified candidates to
fill positions on the ACBSA that are
scheduled to be vacated in the public
member category. The positions are
scheduled to be vacated on or before
December 31, 2007.
A copy of the Committee charter and
roster of the current membership can be
obtained by contacting Dr. Holmberg or
by accessing the ACBSA Web site at
https://www.hhs.gov/bloodsafety.
Nominations
In accordance with the charter,
persons nominated for appointment as
members of the ACBSA should be
among authorities knowledgeable in
blood banking, transfusion medicine,
plasma therapies, transfusion and
transplantation safety, bioethics, and/or
related disciplines. Nominations should
be typewritten. The following
information should be included in the
package of material submitted for each
individual being nominated for
consideration of appointment: (a) The
name, return address, daytime
telephone number and affiliation(s) of
the individual being nominated, the
basis for the individual’s nomination,
the category for which the individual is
being nominated, and a statement
bearing an original signature of the
nominated individual that, if appointed,
he or she is willing to serve as a member
of the Committee; (b) the name, return
address, and daytime telephone number
at which the nominator may be
contacted. Organizational nominators
must identify a principal contact person
in addition to the contact; and (c) a copy
of a current curriculum vitae or resume
for the nominated individual.
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The letter
from the nominator and certification of
the nominated individual must bear
original signatures; reproduced copies
of these signatures are not acceptable.
E:\FR\FM\30JYN1.SGM
30JYN1
Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices
The Department of Health and Human
Services is committed to ensuring that
women, minority groups, and
individuals with physical disabilities
are adequately represented on the
Committee. Nominations of qualified
candidates from these categories are
encouraged. The Department also seeks
to have geographic diversity reflected in
the composition of the Committee.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of the ACBSA are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
Dated: July 23, 2007.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. E7–14611 Filed 7–27–07; 8:45 am]
BILLING CODE 4150–41–P
National Institute for Occupational
Safety and Health; Designation of a
Class of Employees for Addition to the
Special Exposure Cohort
The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at the Los Alamos National
Laboratory, Los Alamos, New Mexico,
as an addition to the Special Exposure
Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000. On
June 22, 2007, the Secretary of HHS
designated the following class of
employees as an addition to the SEC:
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
mstockstill on PROD1PC66 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
SUMMARY:
Decision To Evaluate a Petition To
Designate a Class of Employees at
Lawrence Livermore National
Laboratory, Livermore, CA, To Be
Included in the Special Exposure
Cohort
SUMMARY: The Department of Health and
Human Services (HHS) gives notice as
required by 42 CFR 83.12(e) of a
decision to evaluate a petition to
designate a class of employees at
Lawrence Livermore National
Laboratory, Livermore, California, to be
Jkt 211001
1975, or in combination with work days
within the parameters established for one or
more other classes of employees in the
Special Exposure Cohort.
This designation will become
effective on July 22, 2007, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 07–3688 Filed 7–27–07; 8:45 am]
BILLING CODE 4160–17–M
BILLING CODE 4163–19–M
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
National Institute for Occupational
Safety and Health
22:24 Jul 27, 2007
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 07–3687 Filed 7–27–07; 8:45 am]
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
included in the Special Exposure Cohort
under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. The initial
proposed definition for the class being
evaluated, subject to revision as
warranted by the evaluation, is as
follows:
Facility: Lawrence Livermore National
Laboratory.
Location: All areas.
Job Titles and/or Job Duties: All
workers.
Period of Employment: January 1,
1950 through December 31, 1973.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
41509
Employees of the Department of Energy
(DOE), its predecessor agencies, or DOE
contractors or subcontractors who were
monitored or should have been monitored for
radiological exposures while working in
operational Technical Areas with a history of
radioactive material use at the Los Alamos
National Laboratory (LANL) for a number of
work days aggregating at least 250 work days
from March 15, 1943 through December 31,
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for Occupational
Safety and Health; Designation of a
Class of Employees for Addition to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at the W.R. Grace site, Erwin,
Tennessee, as an addition to the Special
Exposure Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000. On
June 22, 2007, the Secretary of HHS
designated the following class of
employees as an addition to the SEC:
Atomic Weapons Employer (AWE)
employees who were monitored or should
have been monitored for potential exposure
to thorium while working in any of the 100
series buildings or Buildings 220, 230, 233,
234, 301, or 310 at the W.R. Grace site at
Erwin, Tennessee for a number of work days
aggregating at least 250 work days from
January 1, 1958 through December 31, 1970,
or in combination with work days within the
parameters established for one or more other
classes of employees in the Special Exposure
Cohort.
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 72, Number 145 (Monday, July 30, 2007)]
[Notices]
[Pages 41508-41509]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-14611]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the Advisory
Committee on Blood Safety and Availability
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of Public Health and Science (OPHS) is seeking
nominations of qualified individuals to be considered for appointment
as members of the Advisory Committee on Blood Safety and Availability
(ACBSA). ACBSA is a Federal advisory committee in the Department of
Health and Human Services. Management support for the activities of
this Committee are the responsibility of the OPHS.
The qualified individuals will be nominated to the Secretary of the
Department of Health and Human Services for consideration of
appointment as members of the ACBSA. Members of the Committee,
including the Chair, are appointed by the Secretary. Members are
invited to serve on the Committee for overlapping four-year terms.
DATES: All nominations must be received no later than 4 p.m. EDT on
August 31, 2007 at the address listed below.
ADDRESSES: All nominations should be mailed or delivered to Dr. Jerry
Holmberg, Executive Secretary, Advisory Committee on Blood Safety and
Availability; Office of Public Health and Science; Department of Health
and Human Services; 1101 Wootton Parkway, Suite 250; Rockville, MD
20852. Telephone: (240) 453-8803.
FOR FURTHER INFORMATION CONTACT: Dr. Jerry Holmberg, Executive
Secretary, Advisory Committee on Blood Safety and Availability. See
ADDRESSES for contact information.
SUPPLEMENTARY INFORMATION: The Advisory Committee on Blood Safety and
Availability shall provide advice to the Secretary and to the Assistant
Secretary for Health. The Committee shall advise on a range of policy
issues to include: (1) Definition of public health parameters around
safety and availability of the blood and blood products, (2) broad
public health, ethical and legal issues related to transfusion and
transplantation safety, and (3) the implications for safety and
availability of various economic factors affecting product cost and
supply.
The ACBSA consists of 18 voting members. The Committee is composed
of 12 public members, including the Chair, and six (6) representative
members. The public members are selected from State and local
organizations, advocacy groups, provider organizations, academic
researchers, ethicists, private physicians, scientists, consumer
advocates, legal organizations, and from among communities of persons
who are frequent recipients of blood or blood products. The six
individuals who are appointed as official representative members are
selected to serve the interests of the blood and blood products
industry or professional organizations associated with transfusion or
transplantation safety. The representative members are selected from
the following groups: The AABB, the Plasma Protein Therapeutic
Association (PPTA), one of the two major distributors of blood on a
rotating basis, a trade organization or manufacturer of blood, plasma,
or other tissue test kits or equipment, and a purchaser of blood and
blood products from major hospital organization.
All ACBSA members are authorized to receive the prescribed per diem
allowance and reimbursement for travel expenses that are incurred to
attend meetings and conduct Committee-related business, in accordance
with Standard Government Travel Regulations. Individuals who are
appointed to serve as public members are authorized also to receive a
stipend for attending Committee meetings and to carry out other
Committee-related business. Individuals who are appointed to serve as
representative members for a particular interest group or industry are
not authorized to receive a stipend for the performance of these
duties.
This announcement is to solicit nominations of qualified candidates
to fill positions on the ACBSA that are scheduled to be vacated in the
public member category. The positions are scheduled to be vacated on or
before December 31, 2007.
A copy of the Committee charter and roster of the current
membership can be obtained by contacting Dr. Holmberg or by accessing
the ACBSA Web site at https://www.hhs.gov/bloodsafety.
Nominations
In accordance with the charter, persons nominated for appointment
as members of the ACBSA should be among authorities knowledgeable in
blood banking, transfusion medicine, plasma therapies, transfusion and
transplantation safety, bioethics, and/or related disciplines.
Nominations should be typewritten. The following information should be
included in the package of material submitted for each individual being
nominated for consideration of appointment: (a) The name, return
address, daytime telephone number and affiliation(s) of the individual
being nominated, the basis for the individual's nomination, the
category for which the individual is being nominated, and a statement
bearing an original signature of the nominated individual that, if
appointed, he or she is willing to serve as a member of the Committee;
(b) the name, return address, and daytime telephone number at which the
nominator may be contacted. Organizational nominators must identify a
principal contact person in addition to the contact; and (c) a copy of
a current curriculum vitae or resume for the nominated individual.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information. Incomplete nominations will not be processed for
consideration. The letter from the nominator and certification of the
nominated individual must bear original signatures; reproduced copies
of these signatures are not acceptable.
[[Page 41509]]
The Department of Health and Human Services is committed to
ensuring that women, minority groups, and individuals with physical
disabilities are adequately represented on the Committee. Nominations
of qualified candidates from these categories are encouraged. The
Department also seeks to have geographic diversity reflected in the
composition of the Committee.
The Standards of Ethical Conduct for Employees of the Executive
Branch are applicable to individuals who are appointed as public
members of Federal advisory committees. Individuals appointed to serve
as public members of Federal advisory committees are classified as
special Government employees (SGEs). SGEs are Government employees for
purposes of the conflict of interest laws. Therefore, individuals
appointed to serve as public members of the ACBSA are subject to an
ethics review. The ethics review is conducted to determine if the
individual has any interests and/or activities in the private sector
that may conflict with performance of their official duties as a member
of the Committee. Individuals appointed to serve as public members of
the Committee will be required to disclose information regarding
financial holdings, consultancies, and research grants and/or
contracts.
Dated: July 23, 2007.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and
Availability.
[FR Doc. E7-14611 Filed 7-27-07; 8:45 am]
BILLING CODE 4150-41-P
